Concise review: Hematopoietic stem cell aging and the prospects for rejuvenation

Stem Cells Translational Medicine

Volumn 4, Issue 2, 2015, Pages 186-194

  Wahlestedt, Martin ^a   Pronk, Cornelis Jan ^a,b   Bryder, David ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

DNA damage; Epigenetics; Hematopoiesis; Hematopoietic stem cell aging; Rejuvenation

Indexed keywords

ARTICLE; CELL AGING; CELL DIFFERENTIATION; DNA DAMAGE; DNA METHYLATION; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNOCOMPETENCE; INCIDENCE; NONHUMAN; REJUVENATION; ANIMAL; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METABOLISM; NEOPLASMS;

ANIMALS; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; NEOPLASMS; REJUVENATION;

EID: 84921780256     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2014-0132     Document Type: Article

References (102)

1. Westendorp RG. What is healthy aging in the 21st century? Am J Clin Nutr 2006;83: 404S-409S.
2. López-Otín C, Blasco MA, Partridge L et al. The hallmarks of aging. Cell 2013;153:1194-1217.
3. Schumacher B, Garinis GA, Hoeijmakers JH. Age to survive: DNA damage and aging. Trends Genet 2008;24:77-85.
4. Rossi DJ, Jamieson CH, Weissman IL. Stems cells and the pathways to aging and cancer. Cell 2008;132:681-696.
5. Bryder D, Rossi DJ, Weissman IL. Hematopoietic stem cells: The paradigmatic tissuespecific stem cell. Am J Pathol 2006;169: 338-346.
6. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol 2004;5:133-139.
7. Miller JP, Allman D. The decline in B lymphopoiesis in aged mice reflects loss of very early B-lineage precursors. J Immunol 2003; 171:2326-2330.
8. Rossi DJ, Bryder D, Zahn JM et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci USA 2005;102: 9194-9199.
9. Signer RA, Montecino-Rodriguez E, Witte ONet al. Age-related defects in B lymphopoiesis underlie the myeloid dominance of adult leukemia. Blood 2007;110:1831-1839.
10. Muller-Sieburg CE, Cho RH, Karlsson L et al. Myeloid-biased hematopoietic stem cells have extensive self-renewal capacity but generate diminished lymphoid progeny with impaired IL-7 responsiveness. Blood 2004;103: 4111-4118.
11. Gibson KL, Wu YC, Barnett Y et al. B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell 2009;8: 18-25.
12. Goronzy JJ, Lee WW, Weyand CM. Aging and T-cell diversity. Exp Gerontol 2007;42: 400-406.
13. Wahlestedt M, Norddahl GL, Sten G et al. An epigenetic component of hematopoietic stem cell aging amenable to reprogramming into a young state. Blood 2013;121:4257-4264.
14. Dykstra B, Olthof S, Schreuder J et al. Clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells. J Exp Med 2011;208:2691-2703.
15. Norddahl GL, Pronk CJ, Wahlestedt M et al. Accumulating mitochondrial DNA mutations drive premature hematopoietic aging phenotypes distinct from physiological stem cell aging. Cell Stem Cell 2011;8:499-510.
16. Beerman I, Bhattacharya D, Zandi S et al. Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc Natl Acad Sci USA 2010;107:5465-5470.
17. FlorianMC,DörrK,NiebelAet al.Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation. Cell Stem Cell 2012;10:520-530.
18. Sudo K, Ema H, Morita Y et al. Ageassociated characteristics of murine hematopoietic stem cells. J Exp Med 2000;192: 1273-1280.
19. Cho RH, Sieburg HB, Muller-Sieburg CE. A new mechanism for the aging of hematopoietic stem cells: Aging changes the clonal composition of the stem cell compartment but not individual stem cells. Blood 2008;111:5553-5561.
20. Kim M, Moon HB, Spangrude GJ. Major age-related changes of mouse hematopoietic stem/progenitor cells. Ann N Y Acad Sci 2003; 996:195-208.
21. Liang Y, Van Zant G, Szilvassy SJ. Effects of aging onthe homingand engraftment of murine hematopoietic stem and progenitor cells. Blood 2005;106:1479-1487.
22. Rossi DJ, Bryder D, Seita J et al. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 2007;447:725-729.
23. Chambers SM, Shaw CA, Gatza C et al. Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol 2007;5:e201.
24. Pearce DJ, Anjos-Afonso F, Ridler CM et al. Age-dependent increase in side population distribution within hematopoiesis: Implications for our understanding of the mechanism of aging. STEM CELLS 2007;25:828-835.
25. Beerman I, Bock C, Garrison BS et al. Proliferation-dependent alterations of the DNA methylation landscape underlie hematopoietic stem cell aging. Cell Stem Cell 2013;12:413-425.
26. de Haan G, Nijhof W, Van Zant G. Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during aging: Correlation between lifespan and cycling activity. Blood 1997;89:1543-1550.
27. Kollman C,HoweCW,AnasettiCet al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: The effect of donor age. Blood 2001;98:2043-2051.
28. Finke J, Schmoor C, Bethge WA et al. Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: Results from a randomized trial. Biol Blood Marrow Transplant 2012;18:1716-1726.
29. RezvaniAR, StorerBE,GuthrieKAet al. Impact of donor age on outcome after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2014 [Epub ahead of print].
30. Heining C, Spyridonidis A, Bernhardt E et al. Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: A retrospective study including 148 patients. Bone Marrow Transplant 2007;39: 613-622.
31. Weinberg K, Blazar BR, Wagner JE et al. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood 2001;97:1458-1466.
32. Woolthuis CM, Mariani N, Verkaik-Schakel RN et al. Aging impairs long-term hematopoietic regeneration after autologous stem cell transplantation. Biol Blood Marrow Transplant 2014;20:865-871.
33. Kuranda K, Vargaftig J, de la Rochere P et al. Age-related changes inhumanhematopoietic stem/progenitor cells. Aging Cell 2011;10: 542-546.
34. PangWW,Price EA, SahooDet al.Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci USA 2011;108: 20012-20017.
35. Lichtman MA. Battling the hematological malignancies: The 200 years' war. The Oncologist 2008;13:126-138.
36. Jansen MW, Corral L, van der Velden VH et al. Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement. Leukemia 2007;21:633-641.
37. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006; 354:166-178.
38. Challen GA, Boles NC, ChambersSMet al. Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1. Cell Stem Cell 2010;6:265-278.
39. Dykstra B, Kent D, Bowie M et al. Longterm propagation of distinct hematopoietic differentiation programs in vivo. Cell Stem Cell 2007;1:218-229.
40. Morita Y, Ema H, Nakauchi H. Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment. J Exp Med 2010;207:1173-1182.
41. Holstege H, Pfeiffer W, Sie D et al. Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesis. Genome Res 2014;24:733-742.
42. Rando TA. Stem cells, ageing and the quest for immortality. Nature 2006;441: 1080-1086.
43. MedawarPB. An Unsolved Problem of Biology. London, UK: H.K. Lewis, 1952.
44. Williams GC. Pleiotropy, natural selection, and the evolution of senescence. Evolution 1957;11:398-411.
45. Hayflick L. How and Why We Age. New York, NY: Ballantine Books, 1996.
46. Phelan JP, Austad SN. Natural selection, dietary restriction, and extended longevity. Growth Dev Aging 1989;53:4-6.
47. Sahin E, Depinho RA. Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature 2010; 464:520-528.
48. Morrison SJ, Prowse KR, Ho P et al. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 1996;5:207-216.
49. Cheshier SH, Morrison SJ, Liao X et al. In vivo proliferation and cell cycle kinetics of longterm self-renewing hematopoietic stem cells. Proc Natl Acad Sci USA 1999;96:3120-3125.
50. Nygren JM, Bryder D, Jacobsen SE. Prolonged cell cycle transit is a defining and developmentally conserved hemopoietic stem cell property. J Immunol 2006;177:201-208.
51. Allsopp RC, Cheshier S, Weissman IL. Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells. J Exp Med 2001; 193:917-924.
52. Allsopp RC, Morin GB, HornerJWet al. Effect of TERT over-expression on the long-term transplantation capacity of hematopoietic stem cells. Nat Med 2003;9:369-371.
53. Manning EL, Crossland J, Dewey MJ et al. Influences of inbreeding and genetics on telomere length in mice. Mamm Genome 2002; 13:234-238.
54. Lombard DB, Chua KF, Mostoslavsky R et al. DNA repair, genome stability, and aging. Cell 2005;120:497-512.
55. Nijnik A, Woodbine L, Marchetti C et al. DNA repair is limiting for haematopoietic stem cells during ageing. Nature 2007;447:686-690.
56. Cho JS, Kook SH, Robinson AR et al. Cell autonomous and nonautonomous mechanisms drive hematopoietic stem/progenitor cell loss in the absence of DNA repair. STEM CELLS 2013;31:511-525.
57. Chen Y, Ma X, Zhang M et al. Gadd45a regulates hematopoietic stem cell stress responses in mice. Blood 2014;123:851-862.
58. Bender CF, Sikes ML, Sullivan R et al. Cancer predisposition and hematopoietic failure in Rad50(S/S) mice.Genes Dev 2002;16:2237-2251.
59. Navarro S, Meza NW, Quintana-Bustamante O et al. Hematopoietic dysfunction in a mouse model for Fanconi anemia group D1. Mol Ther 2006;14:525-535.
60. Rübe CE, Fricke A, Widmann TA et al. Accumulation of DNA damage in hematopoietic stem and progenitor cells during human aging. PLoS One 2011;6:e17487.
61. Beerman I, Seita J, Inlay MA et al. Quiescent hematopoietic stem cells accumulate DNA damageduring aging that is repaired uponentry into cell cycle. Cell Stem Cell 2014;15:37-50.
62. Sperka T, Wang J, Rudolph KL. DNA damage checkpoints in stem cells, ageing and cancer. Nat Rev Mol Cell Biol 2012;13:579-590.
63. McBride HM, Neuspiel M, Wasiak S. Mitochondria: More than just a powerhouse. Curr Biol 2006;16:R551-R560.
64. Lagouge M, Larsson NG. The role of mitochondrial DNA mutations and free radicals in disease and ageing. J Intern Med 2013;273: 529-543.
65. Liang FQ, Godley BF. Oxidative stressinduced mitochondrial DNA damage in human retinal pigment epithelial cells: A possible mechanism for RPE aging and age-related macular degeneration. Exp Eye Res 2003;76: 397-403.
66. Harman D. The biologic clock: The mitochondria? J Am Geriatr Soc 1972;20:145-147.
67. Larsson NG. Somatic mitochondrial DNA mutations in mammalian aging. Annu Rev Biochem 2010;79:683-706.
68. Wahlestedt M, Ameur A, Moraghebi R et al. Somatic cells with a heavy mitochondrial DNA mutational load render induced pluripotent stem cells with distinct differentiation defects. STEM CELLS 2014;32:1173-1182.
69. Xu X, Duan S, Yi F et al. Mitochondrial regulation in pluripotent stem cells. Cell Metab 2013;18:325-332.
70. Noda S, Ichikawa H, Miyoshi H. Hematopoietic stem cell aging is associated with functional decline and delayed cell cycle progression. Biochem Biophys Res Commun 2009;383:210-215.
71. Sun D, Luo M, JeongMet al. Epigenomic profiling of young and aged HSCs reveals concerted changes during aging that reinforce self-renewal. Cell Stem Cell 2014;14:673-688.
72. Taiwo O, Wilson GA, Emmett W et al. DNA methylation analysis of murine hematopoietic side population cells during aging. Epigenetics 2013;8:1114-1122.
73. SchuettengruberB,Chourrout D,Vervoort Met al. Genome regulation by polycomb and trithorax proteins. Cell 2007;128:735-745.
74. BrackenAP, Kleine-Kohlbrecher D, Dietrich N et al. The polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev 2007;21: 525-530.
75. Krishnamurthy J, Torrice C, Ramsey MR et al. Ink4a/Arf expression is a biomarker of aging. J Clin Invest 2004;114:1299-1307.
76. Attema JL, Pronk CJ, Norddahl GL et al. Hematopoietic stem cell ageing is uncoupled from p16 INK4A-mediated senescence. Oncogene 2009;28:2238-2243.
77. Oguro H, Yuan J, Ichikawa H et al. Poised lineage specification in multipotential hematopoietic stem and progenitor cells by the polycomb protein Bmi1. Cell Stem Cell 2010;6: 279-286.
78. Xie H, Xu J, Hsu JH et al. Polycomb repressive complex 2 regulates normal hematopoietic stem cell function in a developmental-stagespecific manner. Cell Stem Cell 2014;14:68-80.
79. Dhahbi JM. Circulating small noncoding RNAs as biomarkers of aging. Ageing Res Rev 2014;17:86-98.
80. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676.
81. Apostolou E, Hochedlinger K. Chromatin dynamics during cellular reprogramming. Nature 2013;502:462-471.
82. Vierbuchen T, Wernig M. Direct lineage conversions: Unnatural but useful? Nat Biotechnol 2011;29:892-907.
83. Szabo E, Rampalli S, Risue~no RMet al. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 2010;468: 521-526.
84. Pereira CF, Chang B, Qiu J et al. Induction of a hemogenic program in mouse fibroblasts. Cell Stem Cell 2013;13:205-218.
85. Doulatov S, Vo LT, Chou SS et al. Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors. Cell Stem Cell 2013;13:459-470.
86. Riddell J, Gazit R, Garrison BS et al. Reprogramming committed murine blood cells to induced hematopoietic stem cells with defined factors. Cell 2014;157:549-564.
87. Satoh Y, Yokota T, Sudo T et al. The Satb1 protein directs hematopoietic stem cell differentiation toward lymphoid lineages. Immunity 2013;38:1105-1115.
88. Brown K, Xie S, Qiu X et al. SIRT3 reverses aging-associated degeneration. Cell Reports 2013;3:319-327.
89. Johnson SC, Rabinovitch PS, Kaeberlein M. mTOR is a key modulator of ageing and age-related disease. Nature 2013;493:338-345.
90. Chen C, Liu Y, Liu Y et al. mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Sci Signal 2009;2:ra75.
91. Florian MC, Nattamai KJ, Dörr K et al. A canonical to non-canonical Wnt signalling switch in haematopoietic stem-cell ageing. Nature 2013;503:392-396.
92. Ergen AV, Boles NC, Goodell MA. Rantes/Ccl5 influences hematopoietic stem cell subtypes and causes myeloid skewing. Blood 2012;119:2500-2509.
93. Bersenev A, Rozenova K, Balcerek J et al. Lnk deficiency partially mitigates hematopoietic stem cell aging. Aging Cell 2012;11:949-959.
94. Norddahl GL,WahlestedtM, Gisler S et al. Reduced repression of cytokine signaling ameliorates age-induced decline in hematopoietic stem cell function. Aging Cell 2012;11:1128-1131.
95. Cheng CW, Adams GB, Perin L et al. Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression. Cell Stem Cell 2014;14:810-823.
96. Loffredo FS, Steinhauser ML, JaySMet al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell 2013;153:828-839.
97. Katsimpardi L, Litterman NK, Schein PA et al. Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors. Science 2014;344:630-634.
98. SinhaM, Jang YC,OhJ et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science 2014;344:649-652.
99. Rufini A, Tucci P, Celardo I et al. Senescence and aging: The critical roles of p53. Oncogene 2013;32:5129-5143.
100. Kamihara J, Rana HQ, Garber JE. Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome. Hum Mutat 2014;35:654-662.
101. Dussiot M, Maciel TT, Fricot A et al. An activin receptor IIA ligand trap corrects ineffective erythropoiesis in b-thalassemia. Nat Med 2014;20:398-407.
102. Suragani RN, Cadena SM, Cawley SM et al. Transforming growth factor-bsuperfamily ligand trap ACE-536 corrects anemiaby promoting late-stage erythropoiesis. NatMed2014;20: 408-414.